These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31199966)

  • 21. Transcutaneous tibial nerve electrical stimulation versus vaginal electrical stimulation in women with overactive bladder syndrome: Is there a role for short-term interventions?
    Nunes JMO; Gregório EP; Moreira ECH; Hazime FA; Averbeck MA; de Almeida SHM
    Neurourol Urodyn; 2023 Jun; 42(5):1101-1110. PubMed ID: 37042223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
    Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S
    Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder.
    Salatzki J; Liechti MD; Spanudakis E; Gonzales G; Baldwin J; Haslam C; Pakzad M; Panicker JN
    BJU Int; 2019 May; 123(5A):E20-E28. PubMed ID: 30552801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials.
    Huang J; Fan Y; Zhao K; Yang C; Zhao Z; Chen Y; Yang J; Wang T; Qu Y
    Neuromodulation; 2023 Dec; 26(8):1535-1548. PubMed ID: 35989159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
    Canbaz Kabay S; Kabay S; Mestan E; Cetiner M; Ayas S; Sevim M; Ozden H; Karaman HO
    Neurourol Urodyn; 2017 Jan; 36(1):104-110. PubMed ID: 26352904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder.
    Tudor KI; Seth JH; Liechti MD; Ochulor J; Gonzales G; Haslam C; Fox Z; Pakzad M; Panicker JN
    Clin Auton Res; 2020 Feb; 30(1):61-67. PubMed ID: 30074101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder.
    MacDiarmid SA; Peters KM; Shobeiri SA; Wooldridge LS; Rovner ES; Leong FC; Siegel SW; Tate SB; Feagins BA
    J Urol; 2010 Jan; 183(1):234-40. PubMed ID: 19913821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-year safety and efficacy outcomes for the treatment of overactive bladder using a long-lived rechargeable sacral neuromodulation system.
    Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Perrouin-Verbe MA; Elneil S
    Neurourol Urodyn; 2020 Apr; 39(4):1108-1114. PubMed ID: 32243625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center.
    van Breda HMK; Martens FMJ; Tromp J; Heesakkers JPFA
    J Urol; 2017 Jul; 198(1):205-210. PubMed ID: 28189576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report.
    Patidar N; Mittal V; Kumar M; Sureka SK; Arora S; Ansari MS
    J Pediatr Urol; 2015 Dec; 11(6):351.e1-6. PubMed ID: 26279104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Percutaneous Tibial Nerve Stimulation for Overactive Bladder in Women and Men at a Safety Net Hospital.
    Jiang JF; Leung AK; Pettitt-Schieber B; Nabavizadeh R; Thomas RL; Brown M; Hafford D; Lay AH; Hammett J; Carney KJ; Filson CP; Master VA
    J Urol; 2020 Feb; 203(2):385-391. PubMed ID: 31518202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving clinical outcomes for women with overactive bladder or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during Stage 1 sacral neuromodulation.
    Marinkovic SP; Ford JC
    BJU Int; 2018 Sep; 122(3):472-479. PubMed ID: 29637712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome.
    Ramírez-García I; Kauffmann S; Blanco-Ratto L; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial.
    Manríquez V; Guzmán R; Naser M; Aguilera A; Narvaez S; Castro A; Swift S; Digesu GA
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():6-10. PubMed ID: 26645117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
    Sonmez R; Yildiz N; Alkan H
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
    Ginsberg D; Schneider T; Kelleher C; Van Kerrebroeck P; Swift S; Creanga D; Martire DL
    BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Multicenter Study Evaluating the FREquency of Use and Efficacy of a Novel Closed-Loop Wearable Tibial Neuromodulation System for Overactive Bladder and Urgency Urinary Incontinence (FREEOAB).
    Goudelocke C; Sobol J; Poulos D; Enemchukwu E; Zaslau S; Dhir R
    Urology; 2024 Jan; 183():63-69. PubMed ID: 37944596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parasacral versus tibial transcutaneous electrical stimulation to treat urinary urgency in adult women: Randomized controlled clinical trial.
    Falcão Padilha J; Arias Avila M; Driusso P
    Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():167-173. PubMed ID: 34773880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subjective and objective responses to PTNS and predictors for success: a retrospective cohort study of percutaneous tibial nerve stimulation for overactive bladder.
    Iyer S; Laus K; Rugino A; Botros C; Lozo S; Botros SM; Goldberg R; Tomezsko J; Gafni-Kane A; Wroblewski K; Sand P
    Int Urogynecol J; 2019 Aug; 30(8):1253-1259. PubMed ID: 30467763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.
    Booth J; Connelly L; Dickson S; Duncan F; Lawrence M
    Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.